Seems to be a lot of excitement on today's news regarding results of trials re experimental targeted melanoma drug PLX4032 which I believe may be backed by Roche.
It is different technology to PAT-SMS and I wonder whether the positive results of this have contributed to the recent fall in our share price.
melanoma trial
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.201M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $455 | 130K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 30295209 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 22489307 | 15 |
View Market Depth
| Last trade - 10.36am 09/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |